共 233 条
[1]
Pangalos MN(2007)Drug development for CNS disorders: strategies for balancing risk and reducing attrition Nat Rev Drug Discov 6 521-532
[2]
Schechter LE(2007)Blood-brain barrier delivery Drug Discov Today 12 54-61
[3]
Hurko O(2014)Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system Adv Drug Deliv Rev 72 94-109
[4]
Pardridge WM(2012)Intranasal delivery of biologics to the central nervous system Adv Drug Deliv Rev 64 614-628
[5]
Aryal M(2016)Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system J Control Release 240 251-266
[6]
Arvanitis CD(2003)Blood-brain barrier drug targeting: the future of brain drug development Mol Interv 3 90-105
[7]
Alexander PM(2014)Current approaches to enhance CNS delivery of drugs across the brain barriers Int J Nanomedicine 9 2241-2257
[8]
McDannold N(2009)Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB) Eur J Pharm Biopharm 71 251-256
[9]
Lochhead JJ(2002)Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway Pharmacol Rev 54 561-587
[10]
Thorne RG(2013)Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface Nat Nanotechnol 8 137-143